Dezerv

Fund Overview

Fund Size

Fund Size

₹287 Cr

Expense Ratio

Expense Ratio

2.37%

ISIN

ISIN

INF966L01CG3

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

18 Jul 2023

About this fund

quant Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by Quant Mutual Fund. This fund has been in existence for 11 months and 24 days, having been launched on 18-Jul-23.
As of 11-Jul-24, it has a Net Asset Value (NAV) of ₹15.55, Assets Under Management (AUM) of 286.83 Crores, and an expense ratio of 2.37%.
  • quant Healthcare Fund Regular Growth has given a CAGR return of 55.37% since inception.
  • The fund's asset allocation comprises around 97.35% in equities, 0.00% in debts, and 2.65% in cash & cash equivalents.
  • You can start investing in quant Healthcare Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

+55.37%

(Cat Avg.)

Portfolio Summaryas of 30th June 2024

Equity279.24 Cr97.35%
Others7.59 Cr2.65%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Poly Medicure LtdEquity28.74 Cr9.50%
GlaxoSmithKline Pharmaceuticals LtdEquity26.78 Cr8.85%
Aurobindo Pharma LtdEquity26.24 Cr8.68%
Pfizer LtdEquity24.61 Cr8.14%
Zydus Lifesciences LtdEquity20.94 Cr6.92%
Dr Reddy's Laboratories LtdEquity20.9 Cr6.91%
Aarti Pharmalabs LtdEquity17.16 Cr5.67%
Kovai Medical Center & Hospital LtdEquity16.9 Cr5.59%
Indraprastha Medical Corp LtdEquity15.97 Cr5.28%
Gujarat Themis Biosyn LtdEquity15.24 Cr5.04%
SMS Pharmaceuticals LtdEquity13.44 Cr4.44%
Aster DM Healthcare Ltd Ordinary SharesEquity12.17 Cr4.02%
Sequent Scientific LtdEquity11.33 Cr3.75%
Granules India LtdEquity10.35 Cr3.42%
Suven Life Sciences LtdEquity8.73 Cr2.89%
Sanofi India LtdEquity7.7 Cr2.55%
Treps 01-Jul-2024 Depo 10Cash - Repurchase Agreement7.52 Cr2.48%
AstraZeneca Pharma India LtdEquity7.26 Cr2.40%
91 DTB 15082024Bond - Gov't/Treasury4.96 Cr1.64%
Nca-Net Current AssetsCash - Collateral-4.47 Cr1.48%
Brooks Laboratories LtdEquity4.2 Cr1.39%
Sanofi Consumer Healthcare India LimitedEquity2.98 Cr0.99%
Sbi Life Insurance Company Limited 25/07/2024Equity - Future2.81 Cr0.93%

Allocation By Market Cap (Equity)

Large Cap Stocks

6.91%

Mid Cap Stocks

24.45%

Small Cap Stocks

64.08%

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare288.68 Cr95.44%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

14.65%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.55

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

0.92

Higher the better

Fund Managers

Sanjeev Sharma

Sanjeev Sharma

Since July 2023

VS

Vasav Sahgal

Since July 2023

AA

Ankit A. Pande

Since July 2023

ST

Sandeep Tandon

Since July 2023

Additional Scheme Detailsas of 30th June 2024

ISIN
INF966L01CG3
Expense Ratio
2.37%
Exit Load
1.00%
Fund Size
₹287 Cr
Age
18 Jul 2023
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹13.07 Cr47.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹713.42 Cr48.3%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹713.42 Cr46.2%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹29.73 Cr45.3%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹166.33 Cr43.7%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹166.33 Cr40.9%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2312.48 Cr46.8%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2312.48 Cr44.6%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹638.88 Cr48.8%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹17.23 Cr44.2%

About the AMC

Total AUM

₹85,552 Cr

Address

A.M. Road, Prabhadevi, Mumbai, 400025

Other Funds by Quant Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
Quant Commodities Fund Direct Growth

Very High Risk

0.8%1.0%₹368.13 Cr-
Quant Momentum Fund Direct Growth

Very High Risk

0.7%1.0%₹1920.46 Cr-
Quantum Small Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹52.07 Cr-
Quant Teck Fund Direct Growth

Very High Risk

0.8%1.0%₹355.97 Cr-
360 ONE Quant Fund Direct Growth

Very High Risk

0.4%1.0%₹324.32 Cr64.9%
Quant Value Fund Direct Growth

Very High Risk

0.5%1.0%₹1914.73 Cr76.3%
Nippon India Quant Fund Direct Growth

Very High Risk

0.5%0.0%₹70.77 Cr45.6%
Quant BFSI Fund Direct Growth

Very High Risk

0.7%1.0%₹560.28 Cr66.2%
quant Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹286.83 Cr-
DSP Quant Fund Direct Growth

Very High Risk

0.6%0.0%₹1152.87 Cr23.4%
ICICI Prudential Quant Fund Direct Growth

Very High Risk

0.6%1.0%₹88.58 Cr38.5%
Axis Quant Fund Direct Growth

Very High Risk

0.7%1.0%₹1117.51 Cr36.8%
Quant Quantamental Fund Direct Growth

Very High Risk

0.6%1.0%₹2563.88 Cr64.5%
Tata Quant Fund Direct Growth

Very High Risk

0.9%1.0%₹63.29 Cr37.9%
Quant Focused fund Direct Growth

Very High Risk

0.7%1.0%₹1059.04 Cr50.6%
Quant Large and Mid Cap Fund Direct Growth

Very High Risk

0.7%1.0%₹3290.34 Cr67.6%
Quant Active Fund Direct Growth

Very High Risk

0.6%1.0%₹10758.37 Cr54.2%
Quant Small Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹22967.17 Cr68.7%
Quant Absolute Fund Direct Growth

Very High Risk

0.8%1.0%₹2216.28 Cr39.9%
Quant Infrastructure Fund Direct Growth

Very High Risk

0.7%0.0%₹3881.58 Cr83.1%
Quant Multi Asset Fund Direct Growth

High Risk

0.7%1.0%₹2541.51 Cr48.2%
Quant Flexi Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹6885.18 Cr64.0%
Quant Tax Plan Direct Growth

Very High Risk

0.8%0.0%₹9860.39 Cr60.8%
Quant Liquid Plan Direct Growth

Low to Moderate Risk

0.3%0.0%₹2627.97 Cr7.2%
Quant Mid Cap Fund Direct Growth

Very High Risk

0.6%0.0%₹8747.40 Cr72.8%
Quant Gilt Fund Direct Growth

Moderate Risk

0.5%0.0%₹92.35 Cr7.3%
Quant Manufacturing Fund Direct Growth

Very High Risk

0.8%1.0%₹786.81 Cr-
Quant Business Cycle Fund Direct Growth

Very High Risk

0.6%1.0%₹1276.85 Cr73.7%
Quant ESG Equity Fund Direct Growth

Very High Risk

0.8%1.0%₹278.56 Cr54.8%
Quant Overnight Fund Direct Growth

Low Risk

0.1%0.0%₹241.05 Cr7.3%
Quant Large Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹1168.46 Cr48.6%
Quant Dynamic Asset Allocation Fund Direct Growth

Very High Risk

0.7%1.0%₹1148.29 Cr56.9%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of quant Healthcare Fund Regular Growth, as of 11-Jul-2024, is ₹15.55.
The fund's allocation of assets is distributed as 97.35% in equities, 0.00% in bonds, and 2.65% in cash and cash equivalents.
The fund managers responsible for quant Healthcare Fund Regular Growth are:-
  1. Sanjeev Sharma
  2. Vasav Sahgal
  3. Ankit A. Pande
  4. Sandeep Tandon